Outcomes of ovarian cancer patients treated with platinum or non-platinum based chemotherapy after PARP inhibitor maintenance.

被引：3
|
作者：
Brann, Ralynn [1 ]
Kremer, Kevin Michael [1 ]
Carlson, Matthew [1 ]
LoCoco, Salvatore [1 ]
Lea, Jayanthi Sivasothy [1 ]
Miller, David Scott [1 ]
Lee, Jessica [1 ]
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.5563
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5563
引用
收藏
页数：3
相关论文
共 50 条
  • [1] OPERA: a phase II trial of oregovomab plus non-platinum chemotherapy in PARP inhibitor/platinum-resistant ovarian cancer
    Park, Junsik
    Cho, Hyun Woong
    Lim, Myong Cheol
    Choi, Chel Hun
    Lee, Jung-Yun
    [J]. FUTURE ONCOLOGY, 2024,
  • [2] Platinum vs non-platinum chemotherapy for platinum-resistant ovarian cancer: A meta-analysis.
    Rumyantsev, Alexey
    Tyulyandina, Alexandra
    Fedyanin, Mikhail
    Pokataev, Ilya
    Glazkova, Elena
    Israelyan, Edgar
    Tjulandin, Sergei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17551 - E17551
  • [3] Efficacy of a platinum-based chemotherapy rechallenge for platinum-sensitive recurrence after PARP inhibitor maintenance
    Nakao, Takehiro
    Harano, Kenichi
    Wakabayashi, Masashi
    Naito, Yoichi
    Tanabe, Hiroshi
    Mukohara, Toru
    [J]. GYNECOLOGIC ONCOLOGY REPORTS, 2024, 55
  • [4] Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
    Amarasena, Isuru U.
    Walters, Julia A. E.
    Wood-Baker, Richard
    Fong, Kwun
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (04):
  • [5] Platinum versus non-platinum chemotherapy regimens for small cell lung cancer
    Amarasena, Isuru U.
    Chatterjee, Saion
    Walters, Julia A. E.
    Wood-Baker, Richard
    Fong, Kwun M.
    [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (08):
  • [6] Outcomes of ERCC1 high locally advanced esophageal cancer patients treated with non-platinum vs platinum based CRT.
    Yogarajah, Meera
    Stroud, Chipman Robert Geoffrey
    Hegde, Aparna Madhukeshwar
    Walker, Paul R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [7] Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer
    Vacheresse, Genevieve MacAulay
    Sabri, Elham
    Domingo, Sheryl
    Le, Tien
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [8] RESPONSE TO SUBSEQUENT PLATINUM-BASED CHEMOTHERAPY POST PARP INHIBITOR IN RECURRENT EPITHELIAL OVARIAN CANCER
    Vacheresse, Genevieve Macaulay
    Le, Tien
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A251 - A251
  • [9] Response to subsequent platinum-based chemotherapy post PARP inhibitor in recurrent epithelial ovarian cancer
    Vacheresse, Genevieve Macaulay
    Le, Tien
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A194 - A194
  • [10] Effects of PARP Inhibitors on Subsequent Platinum-Based Chemotherapy in Patients with Recurrent Ovarian Cancer
    Kokabu, Tetsuya
    Tarumi, Yosuke
    Aoki, Kota
    Okamura, Ayaka
    Aoyama, Kohei
    Kataoka, Hisashi
    Yoriki, Kaori
    Mori, Taisuke
    [J]. CANCERS, 2024, 16 (15)
12345